ABSTRACT Aberrant expression of T‐cell markers in B‐cell lymphomas is rare and can pose diagnostic challenges. We report a case of a 65‐year‐old man presenting with newly developed scalp nodules. Histopathology revealed nodular lymphoid infiltrates composed of large centrocytes and centroblasts.
V. Pfefferle +4 more
wiley +1 more source
Appearances can be deceptive: acute myeloid leukaemia simulating chronic lymphocytic leukaemia. [PDF]
Horsefield BG +5 more
europepmc +1 more source
ABSTRACT Indeterminate cell histiocytosis (ICH) is a clonal proliferative disorder of mononuclear phagocyte cells that shows features of both dendritic and histiocytic cells. Only around 100 cases of ICH were reported, and among them, only 24% of reported cases involve pediatric patients, with a mean age at diagnosis of 50 years.
Seung‐Soo Lee +3 more
wiley +1 more source
Multiparametric Flow Cytometry Panel for Characterization of Mouse T Cell Differentiation and NK Cell Maturation Following Inflammatory Challenge. [PDF]
Bozic T +5 more
europepmc +1 more source
When Small Cells Matter: Diagnosing Bladder Small Cell Carcinoma on Urine Cytology
Small cell carcinoma of the bladder is rare, aggressive and diagnostically challenging on urine cytology. We report a case detected in urine and confirmed by cell block immunohistochemistry, highlighting the importance of careful assessment and limitations of the Paris System.
Haley Corbin +3 more
wiley +1 more source
Molecular Hydrogen Reverses Sepsis-induced Immunoparalysis: Insights from Longitudinal Deep Immunophenotyping. [PDF]
Wu CL +6 more
europepmc +1 more source
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): Morphological mimicry of lymphoid neoplasms. [PDF]
Guo H, Wei Y, Wang C, Guo X, Zhao G.
europepmc +1 more source
The different face of skin‐rash induced by brentuximab vedotin
Summary Background: Brentuximab vedotin (BV) is a targeted therapy for CD30‐expressing lymphomas, including Hodgkin lymphoma (HL) and cutaneous T‐cell lymphoma (CTCL). While peripheral neuropathy is the most common adverse event, BV‐induced skin rashes are less frequent and not well characterized.
Alessandro Pileri +11 more
wiley +1 more source
Special Issue "Flow Cytometry: Applications and Challenges". [PDF]
Falda A.
europepmc +1 more source
Treatment of Leukemia Cutis Secondary to T-Cell Prolymphocytic Leukemia With Upadacitinib. [PDF]
Fraser K, Langille C, Chen LYC, Purdy K.
europepmc +1 more source

